Korro Bio (KRRO) Change in Accured Expenses (2018 - 2026)
Korro Bio (KRRO) posted Change in Accured Expenses of -$205000.0 for Q1 2026, down 111.71% on a QoQ basis from $1.8 million in Q4 2025, and up 91.84% year-over-year from -$106862.2 in Q1 2025.
Korro Bio (KRRO) Change in Accured Expenses (2018 - 2026) Analysis & Trends
Korro Bio's Change in Accured Expenses history runs 9 years deep, the most recent figure standing at -$205000.0 for Q1 2026.
- Quarterly Change in Accured Expenses rose 91.84% year-over-year to -$205000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (up 360.96% YoY) and the FY2025 annual result came in at $1.4 million, up 136.05% from the prior year.
- Change in Accured Expenses was -$205000.0 for Q1 2026 at Korro Bio, down from $1.8 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.0 million in Q2 2025 and bottomed at -$5.0 million in Q1 2024.
- A 5-year average of -$88941.2 and a median of $225000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 767.11% — and 2024, when it tumbled 351.92%.
- Korro Bio's Change in Accured Expenses stood at $357000.0 in 2022, then plunged by 228.85% to -$460000.0 in 2023, then soared by 273.04% to $796000.0 in 2024, then jumped by 119.85% to $1.8 million in 2025, then slumped by 111.71% to -$205000.0 in 2026.
- Business Quant data shows KRRO's Change in Accured Expenses at -$205000.0 in Q1 2026, $1.8 million in Q4 2025, and $189000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 931,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -16.82 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -16.74 Mn |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | -205,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -205,000.00 |
| Mar 31, 2026 | -205,000.00 |
| Dec 31, 2025 | 1.75 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | 189,000.00 |
| Sep 30, 2025 | 189,000.00 |
| Jun 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | -2.51 Mn |
| Mar 31, 2025 | -2.51 Mn |
| Dec 31, 2024 | 796,000.00 |
| Dec 31, 2024 | 796,000.00 |
| Sep 30, 2024 | -716,000.00 |
| Sep 30, 2024 | -716,000.00 |
| Jun 30, 2024 | 999,000.00 |
| Jun 30, 2024 | 999,000.00 |
| Mar 31, 2024 | -5.05 Mn |
| Mar 31, 2024 | -5.05 Mn |
| Dec 31, 2023 | -460,000.00 |
| Dec 31, 2023 | -460,000.00 |